Avita Therapeutics Inc. (NASDAQ:RCEL)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
RCEL Weekly Chart

Old Forum Content for RCEL

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
  • spmeyers: $RCEL watching for phase 3
  • spmeyers: @hjsiegel $RCEL looks like the market agrees with your assessment! nice chart. on my watch list for better entry.
  • hjsiegel: @Dan $RCEL I have been in this stock since I first discovered it about 3 years ago. since then it has had its treatment of burns and other skin defects approved by the FDA and has been listed on NDEK. This is an australian company. After much research I am convinced that its method of treatment is becoming the state of art with regard to burns. In less than a year it has been adopted by over 50 burn centers and hospitals. The method is less invasive, more effective, less recovery time and cheaper than any competitive method. I am satisfied with the fundamentals. I am interested in your take.
Visit the Trading Forum to join in the discussion.
Stock Price $USD 18.81
Change -0.05%
Volume 29,370

Avita Medical is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. In addition to its ASX listing, Avita listed on the Nasdaq in November 2019.

Request Video of RCEL
Already a member? Sign in here.


  • September 23rd, 2021 - 2021 Q4 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 82,200 stock analysis videos
  • Access an ever expanding library (82,200) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!